TCF3 and acute lymphoblastic leukemia: His bone marrow remained in complete remission for over 3 years.23 We also performed prospective evaluation of MRD levels in 16 consecutive cases of t(1;19)‐ALL, treated with an identical regimen, by real‐time RT‐PCR targeting of TCF3‐PBX1.